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ABSTRACT (138 words) 
There are few studies on the obstetrical consequences of dengue fever during pregnancy. To 
determine whether dengue epidemics were associated with an increase in adverse obstetrical 
outcomes, a semi-ecological study combining individual data on obstetrical events from the perinatal 
registry and aggregated exposure data from the epidemiologic surveillance of dengue was conducted 
in Cayenne French Guiana between 2004 and 2007. After adjustment for individual risk factors, this 
semi-ecological analysis showed that an epidemic level of dengue transmission during the first 
trimester was associated with an increased risk of postpartum hemorrhage and preterm birth. The 
associated risks seemed to depend on the epidemic level. Despite its limitations, the present study 
suggests that dengue in the first trimester may be related to preterm birth and to postpartum 
bleeding, thus leading to specific hypotheses that should be tested in prospective studies. 
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INTRODUCTION 
Dengue is an increasing problem in the tropical world. Every year there are between 50 and 
100 million cases of dengue fever and 500,000 cases of dengue hemorrhagic fever worldwide 
1
. 
Given the incidence during dengue epidemics, a significant number of pregnant women must also get 
infected with dengue. However, there are few studies on the obstetrical consequences of dengue 
during pregnancy. There have been reports of severe complications for both the mother and foetus 
of symptomatic dengue in case series in French Guiana 2,3, but, a recent systematic review of the 
published studies was inconclusive for the adverse pregnancy outcomes 4. Most of the available 
studies are case reports or case series with only few comparative studies. Given the lack of data on 
this question and its potential public health importance, it is crucial to conduct further studies. We 
aimed to test the hypothesis that dengue has adverse consequences using a combination of two 
sources: aggregated exposure data from the epidemiologic surveillance of confirmed dengue from 
the Institut Pasteur, and individual obstetrical data from the Perinatal Registry in French Guiana, 
which contains exhaustive individual data on obstetrical events 5. 
 
MATERIALS AND METHODS 
 
Ethics statement 
Adverse maternal outcomes in French Guiana are reported in the Perinatal Registry. This 
registry is completely anonymous, is approved by the Commission Nationale de l’Informatique et des 
Libertés (CNIL) and is managed by the maternal and child care department of the Conseil Général de 
la Guyane. The data access was based on special permissions given by the Conseil Général de la 
Guyane. 
 
Individual obstetrical data  
The Perinatal Registry includes all births (living and dead) in public and private hospitals in 
French Guiana. Data were available for a 4-year period (January 2004 to December 2007). Inclusion 
criteria for births are a gestational age >22 weeks or a weight >500 grams. Each birth is registered by 
an obstetrician or a midwife. The anonymous data is gathered from the mother’s interview, medical 
files, and maternity follow up booklets, which allowed us to compile 28 different items relating to the 
pregnancy and delivery of the infant. Various adverse obstetrical outcomes were studied: preterm 
birth, low birth weight, malformations, preeclampsia, postpartum hemorrhage, and caesarean 
section.  
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Postpartum hemorrhage was defined as bleeding > 500ml for a vaginal delivery and >1000 ml 
for caesarean section. Preeclampsia was defined as blood pressure >160/90 mm Hg and proteinuria 
>0.5 g per 24h after 20 weeks since last menstrual period. A range of malformations (cardiovascular, 
orthopedic, neurological, multiple, and unknown) were pooled into a single variable representing all 
malformations. Down syndrome was excluded from this list. All adverse obstetrical outcomes were 
determined independently of the mother’s dengue fever status at delivery.  The analysis was 
restricted to pregnancies for which pregnant women were living in the urban area of Cayenne 
consisting of the city of Cayenne and its neighboring communes (Matoury, Macouria and Rémire 
Montjoly). The analysis was restricted to this circumscribed area of Cayenne so that dengue cases 
occurred in the area where the women lived, thus genuinely reflecting an increased risk of getting 
dengue during the pregnancy.  For each studied outcome, only pregnancies with no missing data on 
maternal age, gestational time, parity, gravidity and birth weight were used in the analysis. 
 
Aggregated dengue surveillance data 
For each pregnancy, aggregated data from the epidemiologic surveillance of dengue 
confirmed by the National Reference Center for arboviruses, (the Institut Pasteur de la Guyane 
(IPG)), were used. A confirmed dengue diagnosis was defined (i) during the acute phase of the 
disease as positive virus isolation, and/or positive viral RNA detection by reverse transcriptase-
polymerase chain reaction (RT-PCR), and/or positive NS1 antigen detection, and/or positive DENV 
IgM detection; (ii) the diagnosis of early convalescent dengue cases was based on DENV IgM 
detection6. Weekly totals of confirmed cases are transmitted to the Cellule de l’InVS en Region 
Antilles Guyane (CIRE) for epidemiologic surveillance, alert and intervention. We used cases from a 
single reference laboratory so the number of confirmed cases would not be artificially inflated by the 
increase in the number of labs able to perform tests for dengue during the time period of the study. 
 
Statistical methods 
Univariate and multivariate logistic regression models were used to test if dengue epidemic 
levels during the three defined time periods were significant risk factors for various adverse maternal 
outcomes. To calculate the total monthly number of confirmed dengue fever cases, the month of 
delivery and the term at delivery (established using the last menstrual period) were used to 
determine the month of conception. To investigate potential biologic mechanisms of dengue fever 
on pregnancy outcomes, we constructed three periods of exposure for dengue, the first one 
beginning from the estimated month of conception and covering the next two months (first 
trimester). The second one included the three months following the first trimester (second 
trimester). The third one included the last three months before delivery, regardless of the trimester 
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of pregnancy. Since preterm births have an incomplete or absent third trimester, the associated total 
number of dengue cases in the third trimester would be artificially low for preterm births compared 
to term births. The use of the last three months of pregnancy instead of the traditional third 
trimester was used in order to avoid an artificial protective association between dengue in the third 
trimester and adverse outcomes related to gestational duration. Therefore, the last three months of 
pregnancy cannot be interpreted in this study to represent the third trimester, as it may well be a 
combination of data from the second and third trimester. The total number of dengue cases per 
period were categorized (<20, 20-60 and >60) and transformed into indicator variables. This 
categorization roughly corresponded to the level of cases observed during a non epidemic period, a 
moderate epidemic period or a high epidemic period in French Guiana during this time period. To 
control for potential confounding, adjustment variables were also included. The adjustment variables 
were the woman’s age, ethnic origin, gravidity, parity, twin pregnancy, having had a medical follow 
up, the number of ultrasound scans, and having had various pathologies during pregnancy, including 
chronic health conditions of the mother, as well as pregnancy specific medical conditions. Low birth 
weight (<2,500 g) and preterm birth (gestation < 37 weeks) were also included in the model 
depending on the outcome under investigation. Statistical significance was set at p<0.05. All 
statistical analyses were conducted using R 2.12.0 and the package Epicalc 7. 
 
RESULTS 
During the 2004-2007 period, 24,624 pregnancies occurred throughout French Guiana of 
which 11,004 (44.7 %) were among women living in the urban area of Cayenne. Among these 
pregnancies, 10,771 (97.9 %) had no missing data for maternal age, gestational time, parity, gravidity 
and birth weight. Preterm birth, low birth weight, malformations, preeclampsia, postpartum 
hemorrhage, and caesarean section were observed in 1,284 (11.9%), 1,277 (11.9%), 160 (1.4%), 240 
(2.2 %), 393 (3.6 %) and 2,154 (20.0 %) pregnancies, respectively. A vast majority of the preterm 
births that occurred during the study period were born between 34-36 weeks of gestation (63.6 %). 
Only 4.1 % were classified as extreme preterm births (gestation < 25 weeks). Figure 1 shows the 
monthly numbers of confirmed dengue cases and the monthly incidences of studied outcomes in the 
Cayenne area during 2004-2007.  
Table 1 shows that after adjusting for potential confounders, dengue epidemic levels were 
statistically significant risk factors during the first trimester of pregnancy for both postpartum 
hemorrhage and preterm birth. For postpartum hemorrhage, a number of confirmed cases of dengue 
≥20 during the first trimester of pregnancy corresponded to an increased adjusted odds ratio ranging 
from 2.39 [1.46, 3.93] to 3.06 [2.04, 4.59], depending on the level of the dengue epidemic. Similarly 
confirmed dengue cases > 60 during the first trimester was significantly associated with preterm 
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birth, adjusted odds ratio of 1.31 [1.06, 1.63]. Furthermore, for postpartum hemorrhage, a number 
of confirmed cases of dengue between 20 and 60 during the second trimester of pregnancy was also 
significantly associated with an increased adjusted odds ratio, adjusted odds ratio of 1.65 [1.01, 
2.68], but not with a number of confirmed cases of dengue >60, adjusted odds ratio of 0.91 [0.57, 
1.46]. No statistically significant association of dengue epidemic levels was found for the other 
studied adverse obstetrical outcomes (low birth weight, malformations, preeclampsia, and caesarean 
section). 
 
DISCUSSION 
Despite its limitations, the present study is the first to examine the relation between the 
magnitude of dengue epidemics and a range of obstetrical outcomes using a combination of 
individual and ecological data. After adjusting for potential confounders, there was a statistically 
significant association between dengue epidemics and postpartum hemorrhage, and between 
dengue epidemics and preterm birth. The measure of association seemed to be in proportion with 
the level of the epidemic.  
It is important to note that the pregnancy registry data and the confirmed dengue totals have 
been calculated per month. Not having exact dates for either dengue cases or delivery information 
results in an imperfect fit between the variables we used to represent the first and second trimesters 
and the last three months of pregnancy and real associated pregnancy periods. Using the total 
number of confirmed cases in Cayenne for 3 months as a reflection of an individual woman’s risk of 
getting dengue is a very coarse reflection of actual dengue cases in pregnant women. It rests on the 
plausible assumption that the number of pregnant women having dengue will be proportional to the 
overall magnitude of the dengue epidemic in the population. Since there were many deliveries 
(n=11,004), during these four years we feel we have adequate statistical power to detect 
associations. Although it is possible that the observed associations could have resulted from an 
information bias in the perinatal records, local experience has indicated that there is an under-
reporting of adverse outcomes in the Perinatal Registry in French Guiana due to the priority given to 
care relative to data collection. For the purpose of this study we assumed that this under-reporting 
was fairly constant during the study period and did not affect the results. It could also be argued that 
a possible synchronous seasonal pattern of both dengue epidemics and studied adverse outcomes 
could also explain the observed relations 8. However, including in the final model a variable 
representing the month of birth did not affect results. Another explanation to the observed 
associations could also be that being exposed to a dengue epidemic implies having a greater 
probability of exposure to vector control pesticides. Thus the “toxic” environment during a dengue 
epidemic is also a potential hypothesis for the observed associations. Furthermore, underlying trends 
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in the data, such as the unexpected decrease of preterm births which was observed in 2007, 
followed by an increase in preterm births, as well as the increased frequency of postpartum 
hemorrhages during most of our study period, makes the interpretation of the significant 
associations more complicated. 
Using aggregated data leads to potential ecological biases. However, except for the “toxic” 
hypothesis, we were not able to identify any other potential explanation that could account for the 
association between dengue epidemics and postpartum hemorrhage and preterm birth. In addition, 
adjustment for a range of potential confounders available in the individual registry data did not 
affect the results. It was counter-intuitive to observe that dengue during the first trimester, and less 
clearly during the second trimester, was linked to postpartum hemorrhage and preterm birth. Direct 
placental damage in the first trimester could lead to placental anatomical and functional 
abnormalities leading to subsequent complications. This could suggest that the pathophysiology of 
postpartum bleeding and preterm birth are not solely linked to acute thrombopenia or endothelial 
dysfunction during dengue, but also to other mechanisms that  have effects after the acute episode. 
It has been shown that dengue infection leads to the synthesis of anti-platelet antibodies 9,10 and anti 
endothelial cell antibodies 10, which can persist months after the initial dengue episode 11. It has been 
speculated that these autoantibodies are linked to shared epitopes between NS1, platelet and 
endothelium surface molecules 10. It is possible that these autoantibodies are also associated with 
postpartum hemorrhage and preterm birth. 
 In this study, no significant association (p<0.05) was seen between dengue epidemic levels 
and other adverse obstetrical outcomes. Previous studies have shown an association between 
dengue infection and low birth weight 4. We have found a trend for an association between dengue 
during the first semester and low birth weight, but not during the second trimester and the last 3 
months of pregnancy (Table 1). However, the ecological design may have not been optimal here to 
detect a significant difference. Similarly, although no significant association was seen, a trend during 
the first trimester seemed to suggest a possible association between dengue epidemic levels and 
malformations. There again, the ecological design combined with the limited number of events for 
this adverse outcome may have not been able to detect a significant association. 
Overall, the present study identified a possible relation between potential exposure to 
dengue epidemics in the first trimester of pregnancy and preterm birth and postpartum hemorrhage. 
Prospective studies on the obstetrical consequences of dengue and their pathophysiology are 
needed to confirm these results and improve our insufficient knowledge of this potentially important 
public health problem. 
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Figure 1: Monthly confirmed dengue cases (lag 0 and 9 months) and incidence of the 6 studied 
adverse obstetrical outcomes in the urban area of Cayenne between 2004 and 2007. 
 
10 
 
Table 1: Univariate and multivariate $ logistic regressions predicting impact of dengue epidemics 
on 6 adverse obstetrical outcomes for 107776 pregnant women residing in the Cayenne area, 
French Guiana. 2004-2007 
 
Outcomes Pregnancy period N confirmed dengue cases N events (%) Crude OR [95%CI] Adj. OR [95%CI] P(Wald's test) 
Preterm birth 
First trimester 
<20 246 (10.5) 1 1 - 
20-60 112 (10.6) 1.00 [0.79, 1.27] 1.17 [0.89, 1.54] 0.268 
>60 926 (12.6) 1.22 [1.05, 1.41] 1.31 [1.06, 1.63] 0.014* 
 <20 198 (11.0) 1 1 - 
Second trimester 20-60 133 (12.2) 1.12 [0.89, 1.42] 1.12 [0.84, 1.5] 0.423 
 >60 953 (12.1) 1.11 [0.95, 1.31] 0.96 [0.71, 1.3] 0.796 
Last 3 months 
<20 164 (12.1) 1 1 - 
20-60 122 (11.1) 0.90 [0.70, 1.16] 0.90 [0.69, 1.17] 0.442 
>60 998 (12.0) 0.99 [0.83, 1.18] 0.95 [0.75, 1.22] 0.702 
Postpartum 
hemorrhage 
First trimester 
<20 45 (1.9) 1 1  
20-60 36 (3.4) 1.78 [1.14, 2.78] 2.39 [1.46, 3.93] < 0.001* 
>60 312 (4.2) 2.25 [1.64, 3.08] 3.06 [2.04, 4.59] < 0.001* 
 <20 58 (3.2) 1 1  
Second trimester 20-60 37 (3.4) 1.05 [0.69, 1.60] 1.65 [1.01, 2.68] 0.044* 
 >60 298 (3.8) 1.18 [0.89, 1.57] 0.91 [0.57, 1.46] 0.689 
Last 3 months 
<20 46 (3.4) 1 1 - 
20-60 51 (4.6) 1.38 [0.92, 2.07] 1.47 [0.95, 2.28] 0.086 
>60 296 (3.6) 1.05 [0.76, 1.44] 0.97 [0.65, 1.45] 0.890 
Low birth weight 
First trimester 
<20 243 (10,4) 1 1 - 
20-60 104 (9,8) 0.93 [0.73, 1.19] 1.02 [0.74, 1.39] 0.907 
>60 930 (12,6) 1.24 [1.07, 1.44] 1.19 [0.97, 1.47] 0.099 
 <20 94 (12.6) 1 1 - 
Second trimester 20-60 76 (10.6) 0.82 [0.60, 1.13] 0.89 [0.59, 1.35] 0.596 
 >60 1107 (11.9) 0.94 [0.75, 1.17] 0.84 [0.62, 1.14] 0.270 
Last 3 months 
<20 170 (12,6) 1 1 - 
20-60 116 (10,5) 0.82 [0.64, 1.05] 0.84 [0.6, 1.17] 0.297 
>60 991 (11,9) 0.94 [0.79, 1.12] 0.9 [0.71, 1.14] 0.395 
Preeclampsia 
First trimester 
<20 47 (2.0) 1 1 - 
20-60 14 (1.3) 0.65 [0.36, 1.18] 0.74 [0.39, 1.41] 0.367 
>60 179 (2.4) 1.21 [0.88, 1.68] 1.22 [0.83, 1.80] 0.304 
 <20 22 (1.9) 1 1 - 
Second trimester 20-60 12 (1.7) 0.56 [0.28, 1.14] 0.57 [0.27, 1.22] 0.148 
 >60 206 (2.2) 0.75 [0.48, 1.17] 0.79 [0.48, 1.29] 0.349 
Last 3 months 
<20 35 (2.6) 1 1 - 
20-60 25 (2.3) 0.87 [0.52, 1.47] 1.06 [0.6, 1.86] 0.842 
>60 180 (2.2) 0.83 [0.58, 1.20] 0.80 [0.53, 1.20] 0.284 
Caesarean section 
First trimester 
<20 431 (18.5) 1 1  
20-60 198 (18.6) 0.65 [0.36, 1.18] 0.74 [0.39, 1.41] 0.367 
>60 1525 (20.7) 1.21 [0.88, 1.68] 1.22 [0.83, 1.80] 0.304 
 <20 159 (21.3) 1 1  
Second trimester 20-60 144 (20.1) 0.56 [0.28, 1.14] 0.57 [0.27, 1.22] 0.148 
 >60 1851 (19.9) 0.75 [0.48, 1.17] 0.79 [0.48, 1.29] 0.349 
Last 3 months 
<20 254 (18.8) 1 1  
20-60 211 (19,2) 0.87 [0.52, 1.47] 1.06 [0.60, 1.86] 0.842 
>60 1689 (20.3) 0.83 [0.58, 1.20] 0.80 [0.53, 1.20] 0.284 
Malformations 
First trimester 
<20 24 (1.0) 1 1  
20-60 18 (1.6) 1.66 [0.90, 3.07] 1.66 [0.88, 3.15] 0.118 
>60 118 (1.7) 1.57 [1.01, 2.44] 1.42 [0.88, 2.28] 0.152 
 <20 13 (1.7) 1 1  
Second trimester 20-60 14 (1.9) 1.12 [0.52, 2.40] 1.15 [0.52, 2.53] 0.729 
 >60 133 (1.4) 0.82 [0.46, 1.45] 0.89 [0.49, 1.62] 0.701 
Last 3 months 
<20 18 (1.3) 1 1  
20-60 14 (1.3) 0.95 [0.47, 1.93] 0.90 [0.43, 1.86] 0.767 
>60 128 (1.5) 1.16 [0.70, 1.90] 1.03 [0.61, 1.75] 0.900 
 
* P-value < 0.05 
$ The adjustment variables in the multivariate models were the woman’s age, ethnic origin, gravidity, parity, twin pregnancy, having had a 
medical follow up, the number of ultrasound scans, and having had various pathologies during pregnancy, including chronic health 
conditions of the mother, as well as pregnancy specific medical conditions. Low birth weight (<2500 g) and preterm birth (gestation < 37 
weeks) were also used depending the outcome under investigation. 
